Recommendations on the Drug Treatment of Psychosis in Parkinson's Disease

American Journal of Medicine

Volumn 123, Issue 4, 2010, Pages

  Friedman, Joseph H ^a  

^a Parkinson's Disease and Movement Disorders Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CHOLINESTERASE INHIBITOR; CLOZAPINE; QUETIAPINE; RISPERIDONE;

DEMENTIA; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; LETTER; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOSIS; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; DIBENZOTHIAZEPINES; HUMANS; PARKINSON DISEASE; PSYCHOTIC DISORDERS; RISPERIDONE;

EID: 77950145559     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.09.027     Document Type: Letter

References (9)

1. Hasnain M., Vieweg W.V.R., Baron M.S., et al. Pharmacological management of psychosis in elderly patients with Parkinsonism. Am J Med 122 (2009) 614-622
2. Parkinson Study Group. Low dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. N Engl J Med 340 (1999) 757-763
3. Ondo W.G., Tintner R., Young K.D., et al. Double blind placebo controlled unforced titration parallel trial of quetiapine for dopamine-induced hallucinations in Parkinson's disease. Mov Disord 20 (2005) 958-963
4. Rabey J.M., Prokhorov T., Minovitz A., et al. Effect of quetiapine in psychotic Parkinson disease patients: a double blind labeled study of 3 months duration. Mov Disord 22 (2007) 313-318
5. Shotbolt P., Samuel M., Fox C., and David A.S. A randomized controlled trial of quetiapine for psychosis in Parkinson's disease. Neuropsychiatr Dis Treatment 5 (2009) 327-332
6. Chou K.L., Borek L.L., and Friedman J.H. Management of psychosis in movement disorder patients. Exp Opin Pharmacother 8 (2007) 935-943
7. Ford B., Lynch T., and Greene P. Risperidone in Parkinson's disease. Lancet 344 (1994) 681
8. Rich S.S., Friedman J.H., and Ott B.R. Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes. J Clin Psychiatry 56 (1995) 556-559
9. Miyasaki J., Shannon K., Voon V., et al. Practice Parameter: evaluation and treatment of depression, psychosis and dementia in Parkinson disease (an evidenced-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66 (2006) 996-1002